Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine
暂无分享,去创建一个
B. Czerniecki | K. Smalley | A. Basu | P. Kalinski | A. Soyano | P. Forsyth | H. Soliman | K. Kodumudi | Corey Gallen | Gabriella Albert | Amber Beyer | P. Rodriguez | J. Datta | Derek R Duckett | D. Duckett | G. Koski | Marie Catherine Lee | Sabrina Awshah | Ricardo Lima Barros Costa | H. Han